⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15647364 | 0.84 | — | — | |
| SCHEMBL13728560 | 0.84 | — | — | |
| SCHEMBL15647930 | 0.84 | — | — | |
| SCHEMBL13728614 | 0.82 | NOS3 (0.30) | — | |
| SCHEMBL26503785 | 0.79 | — | — | |
| SCHEMBL1447713 | 0.76 | — | — | |
| SCHEMBL23590399 | 0.74 | — | — | |
| SCHEMBL1345839 | 0.74 | — | — | |
| SCHEMBL1104692 | 0.72 | — | — | |
| SCHEMBL804429 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118589049-A | Electrolyte and lithium ion battery | 泰安市法拉第能源科技有限公司 | 2024-09-03 | — | — | CN | claimed |
| EP-2705049-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-10-19 | — | — | EP | claimed |
| US-8957203-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-02-17 | — | — | US | claimed |
| EP-2705049-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2014-03-12 | — | — | EP | claimed |
| WO-2012151195-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-11-08 | — | — | WO | claimed |
| JP-4159273-A | — | — | None | — | — | JP | disclosed |
| CN-118589049-A | Electrolyte and lithium ion battery | 泰安市法拉第能源科技有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20240234818-A1 | ELECTROLYTE AND BATTERY CELL, BATTERY, AND ELECTRICAL DEVICE CONTAINING SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240234818-A1 | ELECTROLYTE AND BATTERY CELL, BATTERY, AND ELECTRICAL DEVICE CONTAINING SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-07-11 | — | — | US | disclosed |
| WO-2024145811-A1 | ELECTROLYTE SOLUTION, SECONDARY BATTERY COMPRISING SAME, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-07-11 | — | — | WO | disclosed |
| CN-116487574-A | Pre-lithiated anode material, preparation method thereof, pre-lithiated electrochemical device and application | 楚能新能源股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-112752742-A | Hydrofluoroethers and methods of use thereof | 3M创新有限公司 | 2021-05-04 | — | — | CN | disclosed |
| US-8440706-B2 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-05-14 | — | — | US | disclosed |
| US-8372873-B2 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-02-12 | — | — | US | disclosed |
| WO-2012151195-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-11-08 | — | — | WO | disclosed |
| US-20070179167-A1 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED | 2007-08-02 | — | — | US | disclosed |
| CN-1812981-A | Heteroaryloxy nitrogenous saturated heterocyclic derivative | BANYU PHARMA CO LTD (JP) | 2006-08-02 | — | — | CN | disclosed |
| CN-1478077-A | Benzamide compounds as APO B secretion inhibitors | ����ҩƷ��ҵ��ʽ���� | 2004-02-25 | — | — | CN | disclosed |
| US-20010031740-A1 | Methods for delivering compounds into a cell | IMARX PHARMACEUTICAL CORPORATION | 2001-10-18 | — | — | US | disclosed |
| JP-H04159273-A | FLUOROALKYL GROUP-CONTAINING TETRAHYDROFURAN DERIVATIVE AND ITS PRODUCTION | NIPPON OIL & FATS CO LTD | 1992-06-02 | — | — | JP | disclosed |